ADCT — ADC THERAPEUTICS SA

Ownership history in Walleye Capital LLC  ·  6 quarters on record

This page tracks every 13F SEC filing in which Walleye Capital LLC reported a position in ADC THERAPEUTICS SA (ADCT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.19% (2022 Q2)
Avg. % of fund
0.07%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 177,032 -336,586 -65.5% 0.00% $708K $4.00
2022 Q4 REDUCED 513,618 -182,645 -26.2% 0.04% $2.0M $3.84
2022 Q3 REDUCED 696,263 -192,437 -21.7% 0.06% $3.4M $4.82
2022 Q2 ADDED 888,700 +640,346 +257.8% 0.19% $7.1M $7.95
2022 Q1 ADDED 248,354 +202,876 +446.1% 0.07% $3.6M $14.69
2021 Q4 INITIATED 45,478 — — 0.02% $919K $20.20
% of Fund (quarterly)    ADCT price (monthly, adj. close)

Other funds also holding ADCT

As of 2025 Q4 — sorted by position size

Vantage Consulting Group Inc 3Y 12.23% Prosight Management, LP 3Y 7Y 6.18% Redmile Group, LLC 3Y 7Y 4.07% TCG Crossover Management, LLC 3Y 1.33% PLATINUM INVESTMENT MANAGEMENT LTD 3Y 7Y 0.81% Nantahala Capital Management, LLC 3Y 7Y 0.64% ORBIMED ADVISORS LLC 3Y 7Y 0.42% STEMPOINT CAPITAL LP 0.3% Blue Owl Capital Holdings LP 3Y 0.22% EVENTIDE ASSET MANAGEMENT, LLC 3Y 7Y 0.19%
← Back to Walleye Capital LLC Holdings